• Sonuç bulunamadı

Author response: Papillary RCC and oncocytoma: Longer follow-up reported

N/A
N/A
Protected

Academic year: 2021

Share "Author response: Papillary RCC and oncocytoma: Longer follow-up reported"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

CUAJ • March-April 2015 • Volume 9, Issues 3-4 © 2015 Canadian Urological Association

Papillary RCC and oncocytoma:

Longer follow-up reported

cuaj letters

88

Michael S. Floyd Jr, MCh, FRCS (Urol); Alan R. DeBolla, MD, FRCS, FEBU

Department of Urology, Wrexham Maelor Hospital, Wrexham, Wales, United Kingdom

Cite as: Can Urol Assoc J 2015;9(3-4):88. http://dx.doi.org/10.5489/cuaj.2677 Published online April 13, 2015.

D

ear Editor, We read with great

interest the recent case report by Özer and colleagues,1 in

which the very rare occurrence of a concomitant papillary renal cell car-cinoma and oncocytoma is described. The article highlights the fact that oncocytomas arise from intercalated cells of the collecting ducts and that papillary carcinomas have a different cellular origin; thus the finding of these two separate tumours within a single kidney is exceptionally rare and this is the fourth case described in the lit-erature.

Reliable radiological confirmation of oncocytomas remains difficult, as tomography is frequently unable to distinguish between malignant renal lesions and “benign” oncocytomas,2

and the definitive diagnosis is usually based on final pathological analysis.

However, Cornelis and colleagues3

have explored the possibility that absence of central area signal inver-sion or the presence of a signal drop on chemical shift MRI may assist in ruling out oncocytomas.

We published a case of concomi-tant oncocytoma and papillary renal cell carcinoma in 20114 in a

73-year-old female who presented with hyper-calcaemia and was successfully treated

with a left partial nephrectomy. The incidental finding of hypercalcaemia may not have been due to a para-neoplastic syndrome as the patient underwent excision of a parathyroid adenoma later in 2011.

We had originally operated on this case in 2009 and in light of the recent case described we have reex-amined our patient’s postoperative surveillance. We now have 5 years of follow-up with no recurrence detect-ed (of her left renal tumour) between 2009 and 2014, with the last upper tract ultrasound performed in May 2014 – 54 months following her partial nephrectomy. The patient’s serum cre-atinine is normal. Therefore, although Özer and colleagues1 claim to have

the longest follow-up at 18 months following concomitant oncocytoma and papillary cell carcinoma treated with radical nephrectomy, we have a similar case that remains tumour-free, based on radiological grounds, almost 5 years following partial nephrectomy.

Competing interests: The authors declare no competing financial or personal interests.

References

1. Özer C, Gören MR, Egilmez T, et al. Papillary renal cell carci-noma within a renal oncocytoma: Case report of very rare coexistence. Can Urol Assoc J 2014;8:E928-30. http://dx.doi. org/10.5489/cuaj.1963

2. Choudhary S, Rajesh A, Mayer NJ, et al. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009;64:517-22. http://dx.doi. org/10.1016/j.crad.2008.12.011

3. Cornelis F, Lasserre AS, Tourdias T, et al. Combined late gadolini-um-enhanced and double-echo chemical-shift MRI help to differenti-ate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas. AJR Am J Roentgenol 2013;200:830-8. http://dx.doi.org/10.2214/AJR.12.9122

4. Floyd Jr MS, Javed S, Pradeep KE, et al. Composite oncocy-toma and papillary renal cell carcinoma of the kidney treated by partial nephrectomy: A case report. ScientificWorldJournal 2011;11:1173-7. http://dx.doi.org/10.1100/tsw.2011.120

Correspondence: Mr. Michael S Floyd Jr, Department of Urology, Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, Wales, LL13 7TD, UK; michaelfloyd@nhs.net

Author response:

Papillary RCC and

oncocytoma: Longer

follow-up reported

Cevahir Ozer, MD; Mehmet Resit

Gören, MD; Tulga Egilmez, MD;

Nebil Bal, MD

Baskent University, Adana Research and Medical Center, Adana, Turkey

Cite as: Can Urol Assoc J 2015;9(3-4):88-9. http://dx.doi.org/10.5489/cuaj.2792 Published online April 13, 2015.

CUAJ Letters is an open forum to discuss papers published in CUAJ. Letters are published at the discretion of the editors, and are subject to abridgement and editing for style and content. Letters can be sent to the Editor at journal@cua.org.

(2)

CUAJ • March-April 2015 • Volume 9, Issues 3-4 89

D

ear Editor, The clinical

signi-ficance of papillary renal cell carcinoma (RCC) within renal oncocytoma remains unclear. The tumour volume, tumour subtype and presence of recurrence or metastasis during the follow-up period may be helpful to understand the natural his-tory and the clinical significance of these tumours. Therefore, the current tumour free follow-up period of the case reported by Floyd et al contribu-tes to the literature. However, there is a possibility that their case may be accepted as a papillary adenoma wit-hin a renal oncocytoma because of the small diameters of tumour (1.5 mm).1

Papillary adenomas and papillary RCC

are histologically and cytogenetically identical, and are currently seperated based on size. Tumours ≤5 mm in maximum dimension are believed to have a limited growth potential and are designated as adenomas.2, 3 Thus, our

case stil can be accepted as with the longest tumour free follow-up period concerning papillary RCC within renal oncocytoma with the largest papillary RCC diameter (15 mm).4

Competing interests: The authors declare no competing financial or personal interests.

References

1. Floyd MS Jr, Javed S, Pradeep KE, et al. Composite oncocy-toma and papillary renal cell carcinoma of the kidney treated by partial nephrectomy: A case report. ScientificWorldJournal 2011;11:1173-7. http://dx.doi.org/10.1100/tsw.2011.120 2. Grignon DJ, Eble JN. Papillary and metanephric adenomas of the

kidney. Semin Diagn Pathol 1998;15:41-53.

3. Rowsell C, Fleshner N, Marrano P, et al. Papillary renal cell car-cinoma within a renal oncocytoma: Case report of an incidental finding of a tumour within a tumour. J Clin Pathol 2007;60:426-8. http://dx.doi.org/10.1136/jcp.2006.041129 4. Özer C, Gören MR, Egilmez T, et al. Papillary renal cell

carci-noma within a renal oncocytoma: Case report of very rare coexistence. Can Urol Assoc J 2014;8:E928-30. http://dx.doi. org/10.5489/cuaj.1963

Correspondence: Dr. Cevahir Özer, Baskent University Adana Medical and Research Center, Department of Urology, Adana, Turkey; drcevahir@yahoo.com

Referanslar

Benzer Belgeler

The purpose of this study was to investigate the demo- graphic characteristics, symptoms, medication use, an- algesic need, and treatment methods of endometriosis patients at

a) Specialists specializing in rhythm disorders: Unfortunately, in developing countries, there are no fellowship programs; however, in North America (USA and Canada) and European

In this report, we presented a 21-year-old male patient who underwent surgery for a papil- lary fibroelastoma involving the mitral valve and was fol- lowed-up for five years..

Mount Graham’da (Arizona) yapılmakta olan Büyük Dürbün Teleskopu (LBT), 8,4 m çapındaki ikiz aynaları sayesinde, 11,8 m’lik apertür genişliğine ve 23 m’lik bir

健康學堂 新進醫師 消化內科新任主治醫師黃洸偉先前在台北 榮總接受完整的住院醫師訓練 ,並在本院擔任 研究醫師。

33.1±13.4 mEq/L) were evaluated as having systemic PHA1 and those who had normal sweat chloride level or normal salivary Na level levels were evaluated as having renal PHA1..

patients should be informed about the operation and postopera- tive diet and follow-up; realistic goals for postoperative weight loss should be set up; and patient follow-up should

Another study analysing the effect of PPD and anxiety on infant development indicated that infants with mothers suffering from depression had developmental delays